IN THE HIGH COURT OF DELHI AT NEW DELHI
C. Hari Shankar, J.
Merck Sharp And Dohme Corp. & Anr. – Appellants
Versus
Neptune Life Sciences Pvt. Ltd. & Anr. – Respondents
CS(COMM) 180 of 2021, I.A. 5512 of 2021 & I.A. 15939 of 2021
Decided On : 28-04-2023
Settlement Agreement - Patent Infringement - The court found the settlement agreement between the parties to be lawful and decreed the suit in favor of Defendant 1 based on the terms of the settlement agreement.
Fact of the Case:
The dispute between the parties was settled through mediation, and a settlement agreement dated 14th March 2023 was placed on record. The court found the terms of settlement to be lawful and decreed the suit in favor of Defendant 1 based on the settlement agreement.
Finding of the Court:
The court found the terms of settlement to be lawful and decreed the suit in favor of Defendant 1 based on the settlement agreement. The suit stands decreed qua Defendant 1 in terms of the settlement agreement dated 14th March 2023.
Issues:
Ratio Decidendi:
Final Decision: The suit stands decreed qua Defendant 1 in terms of the settlement agreement dated 14th March 2023, and re-notification is scheduled for Defendant 2 on 25th July 2023. A decree sheet is to be drawn up accordingly, and the plaintiff would be entitled to a refund of court fees, if any, deposited by it.
ORDER (Oral)
1. The dispute between the parties stand settled with the intervention of the Delhi High Court Mediation and Conciliation Centre. The settlement agreement dated 14th March 2023 has been placed on record.
2. The terms of settlement read thus:
"(i) The Defendant No. 1 further state that during the lifetime of IN 209816 which has expired on July 05, 2022, the Defendant No.1 has not indulged in any act of commercially making, using, offering for sale, selling or importing, exporting or otherwise using the subject matter of IN'816 in the manner it has been granted in the patent, which may include other salts etc. With respect to the Defendant No. 1's activities concerning the advertisements for Sitagliptin on its website, the Defendant No. 1 undertakes that in compliance of the interim injunction, had cancelled the licenses for the manufacture of the product Sitagliptin Phosphate & Metformin Hydrochloride immediately after receiving the intimation of the interim injunction dated April 16, 2021, passed against them and has ensured no further manufacturing and distribution of the same during the lifetime of IN 209816; Copy of letter dated 12.01.2023 is annexed herewith as Annexure 'D' and
(ii) The Defendant No. 1 further clarifies that it did not commercially launch the generic version of the pharmaceutical drug Sitagliptin including as HAPPY JAAN M, during the term of IN 209816.
(iii) The Defendant No. 1 undertakes to pay the Plaintiff No. 1 a sum of Rs.2,00,000/- (Rupees Two Lakhs Only) in lieu of settlement of the present proceedings and the Plaintiff No.2 shall have no objection to the same. The said payment of Rs.2,00,000/- shall be paid by way of demand draft/NEFT on or before 20.03.2023. In case of default, the Defendant No. 1 shall be liable to pay interest @ 18% per annum.
(iv) Subject to the undertakings given by the Defendant No. 1 herein, the Plaintiffs forego their claim for damages and rendition of accounts in the proceedings as regards the Defendant No. 1.
(v) The parties agree that they have executed the present settlement agreement by their free will and volition without any force or pressure from anybody. The parties also agree that they have understood the contents of the present Settlement Agreement as the same have been explained to them by the Mediator and their respective counsel, in the presence of each other and they have consented to the same in its true letter and spirit, and as such they shall not dispute the same ever in future.
(vi) That by giving consent to this Settlement Agreement, the Parties hereto state that they have settled all claims, disputes and differences mentioned in and arising out of the Suit in CS (COMM) 180/2021, amicably through the process of mediation, and no further claims or demands against each other arising out of the present Suit.
(vii) The terms and conditions of this settlement are binding upon the Plaintiffs and Defendant No. 1, their associates, representatives, successors, partners, employees, affiliates and assignees-in-business.
(viii) The Hon'ble Court may decree the suit qua defendant No. 1 in terms of the present settlement agreement deed and the suit may proceed against the Defendant No.2 who has not settled the matter.
(ix) The Parties undertake to present themselves before the Hon'ble Court during the virtual/physical court hearing, as the case may be, confirming the terms of the present Settlement Agreement."
3. Learned Counsel for the parties are present on behalf of their respective clients and they undertake on behalf of their respective clients to abide by the terms of settlement.
4. The Court has perused the terms of settlement and find them to be lawful.
5. As such, nothing survives for adjudication in the suit.
6. The suit stands decreed qua Defendant 1 in terms of the aforesaid settlement agreement dated 14th March 2023 and, qua Defendant 2, re-notify on 25th July 2023.
7. Let a decree sheet be drawn up accordingly.
8. The plaintiff would be ent
The court's decision was influenced by the settlement agreement, which was found to be lawful and binding upon the parties, leading to the decree in favor of Defendant 1.
The court's decision was influenced by the lawfulness of the settlement agreement and its impact on the decree of the suit in favor of the plaintiffs.
Settlement terms enforceable under CP Code, where defendant acknowledges patent validity and agrees to refrain from infringing activities.
Infringement of a patent and liability for damages after the expiration of the patent term
The court upheld the legality and validity of the Settlement Agreement, leading to the disposal of the suit.
Settlement agreements in patent infringement cases can lead to the decree of the suit and entitlement to a refund of court fees.
The main legal point established in the judgment is the binding nature of a settlement agreement reached between parties, which can lead to the court decreeing the suit in terms of the settlement and....
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.